Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 765–766 | Cite as

ASO Author Reflections: Prognostic Impact of Body Composition Change After Gastrectomy for Advanced Gastric Cancer

  • Hyung Soon Park
  • Jii Bum Lee
  • Minkyu JungEmail author
ASO Author Reflections



Hyung Soon Park, Jii Bum Lee, and Minkyu Jung have no conflicts of interest to disclose.


  1. 1.
    Noh SH, Park SR, Yang HK, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15:1389–96.CrossRefGoogle Scholar
  2. 2.
    Shizgal HM. Body composition of patients with malnutrition and cancer. Summary of methods of assessment. Cancer. 1985;55:250–3.CrossRefGoogle Scholar
  3. 3.
    Jacquelin-Ravel N, Pichard C. Clinical nutrition, body composition and oncology: a critical literature review of the synergies. Crit Rev Oncol Hematol. 2012;84:37–46.CrossRefGoogle Scholar
  4. 4.
    Ongaro E, Buoro V, Cinausero M, et al. Sarcopenia in gastric cancer: when the loss costs too much. Gastric Cancer. 2017;20:563–72.CrossRefGoogle Scholar
  5. 5.
    Park HS, Kim HS, Beom SH, et al. Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC trial. Ann Surg Oncol. 2018;25:3222–30.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Medical Oncology, Department of Internal Medicine, St. Vincent’s HospitalThe Catholic University of KoreaSuwonKorea
  2. 2.Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer CenterYonsei University College of MedicineSeoulKorea

Personalised recommendations